Dr. Jayvadan PatelDr. Jayvadan Patel is a formulation scientist at Aavis Pharmaceuticals, Hoschton, USA and professor emeritus, faculty of pharmacy, Sankalchand University, Gujarat, India. He has more than 26 years of research, academic, and industry experience. Dr. Jayvadan has published various research papers and co-authored a few books. Department of Science and Technology, Ministry of Science and Technology, Government of India has published International Comparative Research Base (2009-14) and Dr. Patel has been put in an honours list of 4th Rank of the Top 10 authors in the subject area Pharmacology, Toxicology, and Pharmaceutics. He is the recipient of the "AICTE-Visvesvaraya Best Teachers Award-2020" by the All India Council for Technical Education, Government of India, and the APTI-young Pharmacy Teacher Award (2014) by the Association of Pharmaceutical Teachers of India. Dr. Namdev DhasDr. Namdev Dhas is currently working as an assistant professor inthe department of pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Karnataka, India. He received his PhD from the Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat in 2021 and completed his M. Pharmacy in pharmaceutics from North Maharashtra University, Maharashtra. His area of research includes material science and engineering, multimodal therapeutic platforms, and inorganic nanocomposites for cancer therapy. The focus is to synthesize different metal-based nanoplatforms and how their properties will affect the efficiency of therapy and diagnosis. He has published a few research and review articles in international journals. He was recently awarded with an award entitled “Excellent Research in Pharmaceutical Science” by Indian Drug Manufacturing Association (IDMA) and Healthcopeia in july 2022. He also received the “Young Researcher Award 2020” organized by the Institute of Scholars. Dr. Gaurav K. SaraogiDr. Gaurav K. Saraogi, currently working as professor and principal at Sri Aurobindo Institute of Pharmacy, Indore, Madhya Pradesh, India, did his Ph.D. in pharmaceutical sciences from the department of pharmaceutical sciences, Dr. H. S. Gour Central University Sagar, Madhya Pradesh, India in 2010. He has more than seventeen years of experience both in research and academia. His areas of research are nanotechnology and targeted tubercular therapy, dendrimers, transdermal and nasal delivery-based approaches for the effective delivery of drugs and other bio-actives. He has worked as an associate professor at the school of pharmacy and technology management, Shri Vile Parle Kelavani Mandal (SVKM) NMIMS University Shirpur, Maharashtra, India.

• 1 Introduction and Basic considerations of core shell nanoconstructs.- Chapter 1: Introduction to core shell nanoconstructs in cancer theragnostics.- Chapter 2: Physicochemical properties of core shell nanoconstructs.- Chapter 3: Surface chemistries and targeting strategies of core shell nanoconstructs in cancer theragnostics.- Chapter 4: Tumor microenvironment-responsive core shell nanoconstructs in cancer theragnostics  .- Chapter 5: Core shell nanoconstructs for cancer-based biomedical applications.- Chapter 6: Core/multi-shell type of core shell nanoconstructs for cancer theragnostics.- Chapter 7: Core shell nanoconstructs in cancer biosensing: Techniques, Applications, and Fabrication Strategies.- Chapter 8: Characterization and Evaluation techniques for core shell nanoconstructs for cancer theragnostics2 Organic/Organic Core Shell Nanoconstructs.- Chapter 9: Polymer/polymer core shell nanoconstructs for cancer theragnostics    .- Chapter 10:Polymer/Lipid core shell nanoconstructs for cancer theragnostics.- Chapter 11:Lipid/Polymer core shell nanoconstructs for cancer theragnostics   3 Inorganic/Organic Core shell Nanoconstructs .- Chapter 12:Magnetic/Organic core shell nanoconstructs for cancer theragnostics .- Chapter 13:Non-magnetic/Organic core shell nanoconstructs for cancer theragnostics4 Organic/Inorganic Core Shell Nanoconstructs.- Chapter 14:Advances in Organic/Magnetic core shell nanoconstructs for cancer theragnostics.- Chapter 15:Innovative Organic/Non-magnetic core shell nanoconstructs: Pioneering Precision in Cancer Theragnostics5 Inorganic/Inorganic Core Shell Nanoconstructs.- Chapter 16:Silica/Non-silica-based core shell nanoconstructs for cancer theragnostics.- Chapter 17:Semiconductor/Non-semiconductor-based core shell nanoconstructs for cancer theragnostics.- Chapter 18:Lanthanide-based core shell nanoconstructs for cancer theragnostics.- Chapter 19: Upconversion core shell nanoconstructs for cancer theragnostics6 Toxicological and Regulatory Aspects.- Chapter 20: Toxicological aspects of core shell nanoconstructs .- Chapter 21: Clinical applications and Commercialization challenges of core shell nanoconstructs.

Dr. Jayvadan PatelDr. Jayvadan Patel is a formulation scientist at Aavis Pharmaceuticals, Hoschton, USA and professor emeritus, faculty of pharmacy, Sankalchand University, Gujarat, India. He has more than 26 years of research, academic, and industry experience. Dr. Jayvadan has published various research papers and co-authored a few books. Department of Science and Technology, Ministry of Science and Technology, Government of India has published International Comparative Research Base (2009-14) and Dr. Patel has been put in an honours list of 4th Rank of the Top 10 authors in the subject area Pharmacology, Toxicology, and Pharmaceutics. He is the recipient of the "AICTE-Visvesvaraya Best Teachers Award-2020" by the All India Council for Technical Education, Government of India, and the APTI-young Pharmacy Teacher Award (2014) by the Association of Pharmaceutical Teachers of India. Dr. Namdev DhasDr. Namdev Dhas is currently working as an assistant professor inthe department of pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Karnataka, India. He received his PhD from the Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat in 2021 and completed his M. Pharmacy in pharmaceutics from North Maharashtra University, Maharashtra. His area of research includes material science and engineering, multimodal therapeutic platforms, and inorganic nanocomposites for cancer therapy. The focus is to synthesize different metal-based nanoplatforms and how their properties will affect the efficiency of therapy and diagnosis. He has published a few research and review articles in international journals. He was recently awarded with an award entitled “Excellent Research in Pharmaceutical Science” by Indian Drug Manufacturing Association (IDMA) and Healthcopeia in july 2022. He also received the “Young Researcher Award 2020” organized by the Institute of Scholars. Dr. Gaurav K. SaraogiDr. Gaurav K. Saraogi, currently working as professor and principal at Sri Aurobindo Institute of Pharmacy, Indore, Madhya Pradesh, India, did his Ph.D. in pharmaceutical sciences from the department of pharmaceutical sciences, Dr. H. S. Gour Central University Sagar, Madhya Pradesh, India in 2010. He has more than seventeen years of experience both in research and academia. His areas of research are nanotechnology and targeted tubercular therapy, dendrimers, transdermal and nasal delivery-based approaches for the effective delivery of drugs and other bio-actives. He has worked as an associate professor at the school of pharmacy and technology management, Shri Vile Parle Kelavani Mandal (SVKM) NMIMS University Shirpur, Maharashtra, India.

• 1 Introduction and Basic considerations of core shell nanoconstructs.- Chapter 1: Introduction to core shell nanoconstructs in cancer theragnostics.- Chapter 2: Physicochemical properties of core shell nanoconstructs.- Chapter 3: Surface chemistries and targeting strategies of core shell nanoconstructs in cancer theragnostics.- Chapter 4: Tumor microenvironment-responsive core shell nanoconstructs in cancer theragnostics  .- Chapter 5: Core shell nanoconstructs for cancer-based biomedical applications.- Chapter 6: Core/multi-shell type of core shell nanoconstructs for cancer theragnostics.- Chapter 7: Core shell nanoconstructs in cancer biosensing: Techniques, Applications, and Fabrication Strategies.- Chapter 8: Characterization and Evaluation techniques for core shell nanoconstructs for cancer theragnostics2 Organic/Organic Core Shell Nanoconstructs.- Chapter 9: Polymer/polymer core shell nanoconstructs for cancer theragnostics    .- Chapter 10:Polymer/Lipid core shell nanoconstructs for cancer theragnostics.- Chapter 11:Lipid/Polymer core shell nanoconstructs for cancer theragnostics   3 Inorganic/Organic Core shell Nanoconstructs .- Chapter 12:Magnetic/Organic core shell nanoconstructs for cancer theragnostics .- Chapter 13:Non-magnetic/Organic core shell nanoconstructs for cancer theragnostics4 Organic/Inorganic Core Shell Nanoconstructs.- Chapter 14:Advances in Organic/Magnetic core shell nanoconstructs for cancer theragnostics.- Chapter 15:Innovative Organic/Non-magnetic core shell nanoconstructs: Pioneering Precision in Cancer Theragnostics5 Inorganic/Inorganic Core Shell Nanoconstructs.- Chapter 16:Silica/Non-silica-based core shell nanoconstructs for cancer theragnostics.- Chapter 17:Semiconductor/Non-semiconductor-based core shell nanoconstructs for cancer theragnostics.- Chapter 18:Lanthanide-based core shell nanoconstructs for cancer theragnostics.- Chapter 19: Upconversion core shell nanoconstructs for cancer theragnostics6 Toxicological and Regulatory Aspects.- Chapter 20: Toxicological aspects of core shell nanoconstructs .- Chapter 21: Clinical applications and Commercialization challenges of core shell nanoconstructs.

Dr. Jayvadan PatelDr. Jayvadan Patel is a formulation scientist at Aavis Pharmaceuticals, Hoschton, USA and professor emeritus, faculty of pharmacy, Sankalchand University, Gujarat, India. He has more than 26 years of research, academic, and industry experience. Dr. Jayvadan has published various research papers and co-authored a few books. Department of Science and Technology, Ministry of Science and Technology, Government of India has published International Comparative Research Base (2009-14) and Dr. Patel has been put in an honours list of 4th Rank of the Top 10 authors in the subject area Pharmacology, Toxicology, and Pharmaceutics. He is the recipient of the "AICTE-Visvesvaraya Best Teachers Award-2020" by the All India Council for Technical Education, Government of India, and the APTI-young Pharmacy Teacher Award (2014) by the Association of Pharmaceutical Teachers of India. Dr. Namdev DhasDr. Namdev Dhas is currently working as an assistant professor inthe department of pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education (MAHE), Karnataka, India. He received his PhD from the Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat in 2021 and completed his M. Pharmacy in pharmaceutics from North Maharashtra University, Maharashtra. His area of research includes material science and engineering, multimodal therapeutic platforms, and inorganic nanocomposites for cancer therapy. The focus is to synthesize different metal-based nanoplatforms and how their properties will affect the efficiency of therapy and diagnosis. He has published a few research and review articles in international journals. He was recently awarded with an award entitled “Excellent Research in Pharmaceutical Science” by Indian Drug Manufacturing Association (IDMA) and Healthcopeia in july 2022. He also received the “Young Researcher Award 2020” organized by the Institute of Scholars. Dr. Gaurav K. SaraogiDr. Gaurav K. Saraogi, currently working as professor and principal at Sri Aurobindo Institute of Pharmacy, Indore, Madhya Pradesh, India, did his Ph.D. in pharmaceutical sciences from the department of pharmaceutical sciences, Dr. H. S. Gour Central University Sagar, Madhya Pradesh, India in 2010. He has more than seventeen years of experience both in research and academia. His areas of research are nanotechnology and targeted tubercular therapy, dendrimers, transdermal and nasal delivery-based approaches for the effective delivery of drugs and other bio-actives. He has worked as an associate professor at the school of pharmacy and technology management, Shri Vile Parle Kelavani Mandal (SVKM) NMIMS University Shirpur, Maharashtra, India.

• 1 Introduction and Basic considerations of core shell nanoconstructs.- Chapter 1: Introduction to core shell nanoconstructs in cancer theragnostics.- Chapter 2: Physicochemical properties of core shell nanoconstructs.- Chapter 3: Surface chemistries and targeting strategies of core shell nanoconstructs in cancer theragnostics.- Chapter 4: Tumor microenvironment-responsive core shell nanoconstructs in cancer theragnostics  .- Chapter 5: Core shell nanoconstructs for cancer-based biomedical applications.- Chapter 6: Core/multi-shell type of core shell nanoconstructs for cancer theragnostics.- Chapter 7: Core shell nanoconstructs in cancer biosensing: Techniques, Applications, and Fabrication Strategies.- Chapter 8: Characterization and Evaluation techniques for core shell nanoconstructs for cancer theragnostics2 Organic/Organic Core Shell Nanoconstructs.- Chapter 9: Polymer/polymer core shell nanoconstructs for cancer theragnostics    .- Chapter 10:Polymer/Lipid core shell nanoconstructs for cancer theragnostics.- Chapter 11:Lipid/Polymer core shell nanoconstructs for cancer theragnostics   3 Inorganic/Organic Core shell Nanoconstructs .- Chapter 12:Magnetic/Organic core shell nanoconstructs for cancer theragnostics .- Chapter 13:Non-magnetic/Organic core shell nanoconstructs for cancer theragnostics4 Organic/Inorganic Core Shell Nanoconstructs.- Chapter 14:Advances in Organic/Magnetic core shell nanoconstructs for cancer theragnostics.- Chapter 15:Innovative Organic/Non-magnetic core shell nanoconstructs: Pioneering Precision in Cancer Theragnostics5 Inorganic/Inorganic Core Shell Nanoconstructs.- Chapter 16:Silica/Non-silica-based core shell nanoconstructs for cancer theragnostics.- Chapter 17:Semiconductor/Non-semiconductor-based core shell nanoconstructs for cancer theragnostics.- Chapter 18:Lanthanide-based core shell nanoconstructs for cancer theragnostics.- Chapter 19: Upconversion core shell nanoconstructs for cancer theragnostics6 Toxicological and Regulatory Aspects.- Chapter 20: Toxicological aspects of core shell nanoconstructs .- Chapter 21: Clinical applications and Commercialization challenges of core shell nanoconstructs.